The European Commission tabled its review of the pending, $13.35 billion merger between Zimmer (NYSE:ZMH) and Biomet, saying Zimmer’s submission for the June 3 review was insufficient.
Judge cuts Biolase board of directors | Medtech legal news for the week of Mar. 31, 2014
EU launches investigation into pelvic mesh
The European Commission asked a scientific advisory panel to look into the safety of surgical procedures to treat urogynecological conditions using mesh products, which have embroiled their makers in tens of thousands of product liability lawsuits in the U.S.
The EU’s executive body asked its Scientific Committee on Emerging and Newly Identified Health Risks for an opinion on the "safety of surgical meshes used in urogynecological surgery," according to the commission’s request.
American Medical Systems lands CE Mark for transvaginal sling
Avedro wins CE Mark for its KXL II system
Waltham,Mass.-based Avedro said it won CE Mark clearance in the European Union for its KXL II cross-linking system.
The technology uses a photorefractive intrastromal cross-linking procedure for non-surgical correction of myopia as well to improve cataract surgery outcomes, according to a company statement.
Biotronik wins CE Mark for PK Papyrus coronary stent
Biotronik announced today that it won CE Mark approval in the European Union for its PK Papyrus coronary stent system.
The Papyrus device is approved for treating acute coronary artery perforation, and features an innovative “electrospun” membrane to increase flexibility by 58% over its competitors, according to a Biotronik company statement.
Reverse Medical lands CE Mark, 510(k) for brain catheters
Reverse Medical Corp. said it won CE Mark approval in the European Union and 510(k) clearance from the FDA for its ReVerse neurovascular microcatheter device.
The regulatory nods are for use in the neurological, peripheral and coronary vasculature for the infusion of diagnostic and therapeutic agents, according to a press release.
‘Unofficial’ NB inspection requirements published by European Commission
By Stewart Eisenhart, Emergo Group
The European Commission has published an unofficial version of its new regulatory requirements for Notified Bodies that play a key role in CE Mark certification for medical devices.
Although the published requirements contain no reference numbers or dates, the document likely provides a clear indication of how Notified Bodies will have to comply.
Baxter appeases EU regulators in $4B Gambro buyout
E.U. scrutinizes medtech review “shopping” | MassDevice.com On Call
MASSDEVICE ON CALL — Under fire for being too lenient with medical device approvals, European regulators proposed an update to current CE Mark review and approval practices.
Specifically, the European Commission’s proposed changes address the relative ease with which companies can secure CE Mark approval by "shopping" for an agency in a specific country that will most quickly green-light a new device.
Euro device makers cry ‘nay’ on FDA-like proposal for medtech review
Medical device groups were quick to criticize the European Commission’s newly released medical device regulatory guidelines, saying certain updates stall innovation rather than bolster safety.
European medical device lobbying group welcomed most of the proposed measures, but took exception to the so-called "scrutiny procedure," through with a central panel of advisors would monitor the various assessment agencies that currently oversee medical device control in the European Union.
MassDevice Network
@MassDevice
LinkedIn
YouTube